Assignee
SEARLE LLC
US·18 granted patents·12 pending applications·162 citations·filing 1995–2008
Top patents by PatentIndex Score
30 records- 0194US7320983B2α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE LLC·Filed 2006·Granted Jan 22, 2008·8 cites·16 claims
- 0291US7829564B2α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE LLC·Filed 2007·Granted Nov 9, 2010·4 cites·16 claims
- 0390US7339078B2Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE LLC·Filed 2006·Granted Mar 4, 2008·6 cites·18 claims
- 0488US7531538B2α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE LLC·Filed 2006·Granted May 12, 2009·6 cites·19 claims
- 0586US6740663B2Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptakeSEARLE LLC·Filed 2002·Granted May 25, 2004·24 cites·150 claims
- 0686US6586434B2Method for the preparation of tetrahydrobenzothiepinesSEARLE LLC·Filed 2001·Granted Jul 1, 2003·16 cites·32 claims
- 0785US7226932B2Self-emulsifying drug delivery systemSEARLE LLC·Filed 2003·Granted Jun 5, 2007·28 cites·13 claims
- 0878USRE42889Eα- and β- amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSEARLE LLC·Filed 2007·Granted Nov 1, 2011·2 cites·25 claims
- 0977US6458851B1Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indicationsSEARLE LLC·Filed 1999·Granted Oct 1, 2002·35 cites·8 claims
- 1071US7157101B2Micronized eplerenone compositionsSEARLE LLC·Filed 2004·Granted Jan 2, 2007·3 cites·38 claims
- 1168US2008118969A1Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsSEARLE LLC·Filed 2008·Application pending·0 cites
- 1265US2008176842A1Bis-sulfonamide hydroxyethylamino retroviral protease inhibitorsSEARLE LLC·Filed 2007·Application pending·0 cites
- 1363US7297793B2Bis-sulfonamide hydroxyethylamino retroviral protease inhibitorsSEARLE LLC·Filed 2006·Granted Nov 20, 2007·0 cites·20 claims
- 1463US6890958B2Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 2002·Granted May 10, 2005·1 cites·9 claims
- 1561US7022672B2Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitorSEARLE LLC·Filed 2001·Granted Apr 4, 2006·1 cites·85 claims
- 1659US2004110761A1Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disordersSEARLE LLC·Filed 2003·Application pending·0 cites
- 1754US7012094B1Substituted furans and furanones for the treatment of inflammationSEARLE LLC·Filed 1995·Granted Mar 14, 2006·11 cites·12 claims
- 1851US2004176438A1Novel mono- and di-fluorinated beozothiepine copmunds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptakeSEARLE LLC·Filed 2003·Application pending·0 cites
- 1950US2004028644A1Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indicationsSEARLE LLC·Filed 2003·Application pending·0 cites
- 2049US2004048846A1Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 2003·Application pending·0 cites
- 2149US2004082647A1Method for the preparation of tetrahydrobenzothiepinesSEARLE LLC·Filed 2003·Application pending·0 cites
- 2248US6489366B1Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 1999·Granted Dec 3, 2002·6 cites·7 claims
- 2348US6458850B1Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 1999·Granted Oct 1, 2002·6 cites·12 claims
- 2448US2003166720A1Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 2002·Application pending·0 cites
- 2547US2003203892A1Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indicationsSEARLE LLC·Filed 2002·Application pending·0 cites
- 2644US6569905B1Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indicationsSEARLE LLC·Filed 1999·Granted May 27, 2003·4 cites·10 claims
- 2742US2003125316A1Combinations of lleal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 2002·Application pending·0 cites
- 2839US2004058908A1Combinations for cardiovascular indicationsSEARLE LLC·Filed 2002·Application pending·0 cites
- 2938US2003199515A1Method for the preparation of crystalline tetrahydrobenzothiepinesSEARLE LLC·Filed 2002·Application pending·0 cites
- 3034US6638969B1Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 1999·Granted Oct 28, 2003·1 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when SEARLE LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →